GMB-475 exhibited a growth inhibition effect on Ba/F3-MIG-p210 cells with BCR::ABL1T315I+F486S mutations but no significant improvement of prognosis in chronic myeloid leukemia mouse models constructed by this cell line. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.